TG
IBB icon

TLP Group’s iShares Biotechnology ETF IBB Stock Holding History

TLP Group’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-2,197,600
Closed -$2.5M – 15
2019
Q1 		$2.5M Buy
2,197,600
+2,157,162
+5,334% +$237M 34.88% 1
2018
Q4 		$4.4M Sell
40,438
-2,860
-7% -$304K 16.17% 1
2018
Q3 		$5.28M Buy
43,298
+1,863
+4% +$219K 8.35% 2
2018
Q2 		$4.55M Buy
41,435
+8,307
+25% +$888K 6.91% 2
2018
Q1 		$3.54M Buy
33,128
+28,328
+590% +$3.14M 2.42% 6
2017
Q4 		$512K Buy
+4,800
New +$513K 0.36% 22

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
N
Natixis Paris, France $28B AUM 26.79% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

TLP Group's IBB Position: Q2 2019 in Review

TLP Group sold out of iShares Biotechnology ETF (IBB) in Q2 2019, closing a stake of 2,197,600 shares — an estimated $2.5M sold.

TLP Group first reported a position in IBB in Q4 2017 and held it in 6 quarters. The position peaked at $5.28M in Q3 2018. 646 funds tracked by Wall St. Rank hold IBB as of Q2 2019.

  • TLP Group reported no remaining iShares Biotechnology ETF position as of Q2 2019 after selling out during the quarter.
  • TLP Group sold 2,197,600 iShares Biotechnology ETF shares in Q2 2019, an estimated $2.5M.
  • TLP Group first reported a position in iShares Biotechnology ETF in Q4 2017 and held it in 6 quarters.
  • TLP Group's iShares Biotechnology ETF position peaked at $5.28M in Q3 2018.
  • 646 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2019.

Based on TLP Group's 13F filing for Q2 2019, filed 16 Jul 2019.